КІШІ ТЫНЫС ЖОЛДАРЫ АУРУЫ – ӨСОА ЕРТЕ НАҚТАМАЛАУДЫҢ БОЛЖАМЫ
Кіріспе. Өкпенің созылмалы обструктивті ауруын (ӨСОА) ерте анықтау және алдын алу ғылыми және клиникалық тұрғыдан негізгі мәселелр болып табылады. Кіші тыныс алу жолдарының ауруы бұрыннан ӨСОА ерте нақтамалауда үлкен қызығушылық тудыруда. Зерттеулер ӨСОА шалдыққан науқастарда қалыптан тыс спирометрия немесе эмфизема дамығанға дейін кіші тыныс алу жолдарының айтарлықтай бұзылысын мәлімдеді.
Зерттеудің мақсаты өкпенің созылмалы обструктивті ауруын (ӨСОА) ерте нақтамалаудың маңыздылығын көрсететін кіші тыныс алу жолдары қызметінің бұрынғы және жаңа сынақтарының рөлін зерделеу болды.
Іздеу стратегиясы. Келесі дерекқорларда – Medline (2017 – 2024 ж. ақпаны) және Embase (2017 – 2024 ж. ақпаны), соның ішінде Cochrane кітапханасында зерттеу жүргізілді. Іздеу тек ағылшын тілінде жазылған және соңғы 7 жылда жарияланған мақалалармен шектелді. Егжей-тегжейлі шолуды қамтамасыз ету үшін біз келесі терминдерді қолданып әдебиеттерді іздестірдік: «кіші тыныс тыныс алу жолдарының ауруы», «өкпенің созылмалы обструктивті ауруы», «ауа ағынының кедергісі», «өкпе физиологиясы», «өкпенің қызметі» және оған қатысты барлық шектелген терминдерді бір уақытта. Барлығы іріктеу сипатбелгілеріне сәйкес 70 өзекті ғылыми жарияланымдар талдауға алынды.
Нәтижелер. Бұл нәтижелер ӨСОА ерте анықтаудағы кіші тыныс жолдары ауруларының әртүрлі сынақтарының орны туралы маңызды түсінік береді.
Қорытынды. Нәтижелер өкпенің созылмалы обструктивті ауруларын ерте нақтамалаудың маңыздылығын түсінуде кіші тыныс алу жолдары дисфункциясының рөлін көрсетеді, сондықтан оны түсіну науқастардың ем нәтижелерін жақсартады.
Ардақ Жұмағалиева1, https://orcid.org/0000-0002-4928-1339
Роза Бакенова1, https://orcid.org/0000-0002-5024-9096
Мағрипа Кемешова2, https://orcid.org/0009-0009-6551-3951
Меруерт Нәзілова3, https://orcid.org/0009-0001-2026-5044
Жаннұр Нәзілова3, https://orcid.org/0009-0005-8721-5825
1 Қазақстан Республикасы Президентінің Іс Басқармасы Медициналық Орталық Ауруханасы,
Астана қ., Қазақстан Республикасы;
2 «Астана медицина университеті» КеАҚ, Астана қ., Қазақстан Республикасы;
3 «Семей медицина университеті» КеАҚ, Семей қ., Қазақстан Республикасы.
1. Almeshari M.A., Alobaidi N.Y.Edgar R.G., Stockley J., Sapey E. Physiologic tests of small airways function in diagnosing asthma: a systematic review // BMJ Open Respir Res. 2020. 7: e000770
2. Agustí A, Celli BR, Vogelmeier CF. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary // European Respiratory Journal 2023. 61:2300239; DOI: 10.1183/13993003.00239-2023
3. Agusti A., Celli B. Natural history of COPD: gaps and opportunities // ERJ Open Res. 2017; 3: 00117-2017
4. Alhabeeb F.F., Whitmore G.A., Vandemheen K.L. et al. Disease burden in individuals with symptomatic undiagnosed asthma or COPD // Respir Med. 2022. 200:106917. doi: 10.1016/j.rmed.2022.106917
5. Abdo M., Trinkmann F., Kirsten A.M., Pedersen F., Herzmann C., von Mutius E., et al. Study Group. Small airway dysfunction links asthma severity with physical activity and symptom control // J Allergy Clin Immunol Pract. 2021. 9:3359–68. doi: 10.1016/j.jaip.2021.04.035
6. Bhattarai P., Myers S., Chia C., et al. Clinical application of Forced Oscillation Technique (FOT) in early detection of airway changes in smokers // J Clin Med. 2020. 9(9):2778. doi:10.3390/jcm9092778
7. Barkas G.I., Daniil Z., Kotsiou O.S. The Role of Small Airway Disease in Pulmonary Fibrotic Diseases // J. Pers. Med. 2023 : 13. 1600 https://doi.org/10.3390/jpm13111600
8. Berti A., Licini A., Lombardi C., Cottini M. Small airway dysfunction in elderly patient with asthma: a real life study // Eur Respir J. (2018) 52 (suppl 62):PA504. doi: 10.1183/13993003.
9. Belli S, Prince I, Savio G et al. Airway clearance techniques: the right choice for the right patient // Front Med. 2021. 8. https://doi.org/10.3389/fmed.2021.544826.
10. Bhatt S.P., Bodduluri S., Raghav V. et al. The peak index: spirometry metric for airflow obstruction severity and heterogeneity // Ann Am Thorac Soc. 2019;16(8):982–989.
11. Bhatt S.P. Imaging Small Airway Disease: Probabilities and Possibilities // Ann Am Thorac Soc. 2019 Aug.16(8):975-977. doi: 10.1513
12. Celli B, Singh D, Vogelmeier C. New Perspectives on Chronic Obstructive Pulmonary Disease // Int J Chron Obstruct Pulmon Dis. 2022; 17: 2127–2136. doi: 10.2147/COPD.S365771
13. Crisafulli E., Pisi R., Aiello M., et al. Prevalence of small-airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease // Respiration. 2017. 93(1):32-41
14. Cottini M., Lombardi C., Passalacqua G., Bagnasco D., Berti A., Comberiati P., Imeri G., Landi M., Heffler E. Small Airways: The "Silent Zone" of 2021 GINA Report? // Front Med (Lausanne). 2022 May 23. 9:884679. doi: 10.3389/fmed.2022.88467
15. Cottini M., Licini A., Lombardi C., Bagnasco D., Comberiati P., Berti A. Small airway dysfunction and poor asthma control: a dangerous liaison // Clin Mol Allergy. 2021. 19:7. doi: 10.1186/s12948-021-00147-8
16. Choi JY, Rhee CK. Diagnosis and Treatment of Early Chronic Obstructive Lung Disease (COPD). J Clin Med. 2020 Oct 26;9(11):3426. doi: 10.3390/jcm9113426.
17. Chukowry P, Spittle D, Turner A. Small Airways Disease, Biomarkers and COPD: Where are We? // International Journal of Chronic Obstructive Pulmonary Disease 2021:16 351–365.
18. Do Sun Kwon et al. FEF25-75% Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease // International Journal of Chronic Obstructive Pulmonary Disease 2020:15
19. Fazleen A, Wilkinson T. Early COPD: current evidence for diagnosis and management // Therapeutic Advances in Respiratory DiseaseVolume 2020. https://doi.org/10.1177/1753466620942128
20. Ford E.S., Murphy L.B., Khavjou O., Giles W.H., Holt J.B., Croft J.B. Total and state-specific medical and absenteeism costs of COPD among adults aged 18 years in the United States for 2010 and projections through 2020 // Chest. 2015. 147(1):31–45. doi:10.1378/ chest.14-0972
21. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2023 Report. https://goldcopd.org/2023-gold-report-2/
22. Gregory M. Lee, Melissa B. Carroll, Jeffrey R. Galvin, Christopher M. Walker. Mosaic Attenuation Pattern // Radiologic Clinics of North America 2022. 60:6, 963-978 (95)
23. Gupta M. et al. Oscillometry – The future of estimating pulmonary functions // Karnataka Paediatr J 2020. 35(2):79-87
24. Hopkins S.R. et al. The pulmonary vasculature // Semin Respir Critic Care Med. 2023:37816344.
25. Hangaard S., Kronborg T., Hejlesen O.K. Characteristics of subjects with undiagnosed COPD based on post-bronchodilator spirometry data // Respir Care. 2019;64(1):63–70. doi: 10.4187
26. Higham A., Quinn A.M., Cançado J.E. The pathology of small airways disease in COPD: historical aspects and future directions // Respir Res. 2019. 20(1):49.
27. Hogg J.C., Paré P.D., Hackett T.L. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease [published correction appears in Physiol Rev. 2018; 98(3):1909].
28. Hoff B.A., Pompe E., Galbán S., et al. CT-based local distribution metric improves characterization of COPD // SciRep. 2017. 7(1): 2999.
29. Hoesterey D. et al. Spirometric indices of early airflow impairment inindividuals at risk of developing COPD: Spirometry beyond FEV1/FVC. Respiratory Medicine. 2019. 156. 58–68. doi.org/10.1016/j.rmed.2019.08.004
30. Kundu D., Panchagnula M.V. Asymmetric lung increases particle filtration by deposition // Sci Rep. 13, 9040 (2023). https://doi.org/10.1038/s41598-023-36176-3
31. Kay Yip, Stockley R, Sapey E. Catching “Early” COPD – The Diagnostic Conundrum // Int J Chron Obstruct Pulmon Dis. 2021. 16: 957–968. doi: 10.2147/COPD.S296842
32. Kaminsky D, Simpson Sh, Berger K. et al. Clinical significance and applications of oscillometry // European Respiratory Review. 2022. 31: 210208. DOI:10.1183/16000617.0208-2021
33. Kostikas K., Price D., Gutzwiller F.S. et al. Clinical impact and healthcare resource utilization associated with early versus late COPD diagnosis in patients from UK CPRD database // Int J Chron Obstruct Pulmon Dis. 2020. 15:1729–1738. doi: 10.2147/COPD.S255414
34. Kaitlin M. Kenaley, Tom Blackson, Lori Boylan et al. Impact of endotracheal tube biofilm and respiratory secretions on airway resistance and mechanics of breathing in a neonatal lung model // J Appl Physiol125: 1227–1231, 2018. doi:10.1152/japplphysiol.00083.2018.8750-7587/18
35. Kirby M, Smith B. Quantitative CT Scan Imaging of the Airways for Diagnosis and Management of Lung Disease // Chest, 2023: V164, 5:1150-1158
36. Koo H.-K., Vasilescu D.M., Booth S. et al. Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study // Lancet Respir Med. 2018. 6(8):591–602
37. Knox-Brown B, Patel P, Potts J. et al. Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study // The Lancet Global Health. 2023, 11;1:e69-e82
38. Kraft M., Richardson M., Hallmark B., Billheimer D., Van den Berge M., Fabbri L.M. et al. ATLANTIS study group. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study // Lancet Respir Med. 2022 S2213-2600(21)00536-1. doi: 10.1183/13993003.
39. King G.G., Bates J., Berger K.I. et al. Technical standards for respiratory oscillometry // Eur Respir J. 2020. 55:2. doi: 10.1183/13993003.00753.
40. Lin Ch, Cheng Sh, Chen Ch. Current Progress of COPD Early Detection: Key Points and Novel Strategies // Int J Chron Obstruct Pulmon Dis. 2023; 18: 1511–1524.
41. Lundblad LKA, Robichaud A. Oscillometry of the respiratory system: a translational opportunity not to be missed. Am J Physiol Lung Cell Mol Physiol. 2021 Jun 1;320(6):L1038-L1056. doi: 10.1152/ajplung.00222.2020.
42. Martinez F.J., Han M.K., Allinson J.P., et al. At the root: defining and halting progression of early chronic obstructive pulmonary disease // Am J Respir Crit Care Med. 2018. 197: 1540–1551.
43. Mangione C.M., Barry M.J., Nicholson W.K. et al. US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease: US preventive services task force reaffirmation recommendation statement // JAMA. 2022. 327(18):1806–1811. doi: 10.1001/jama.2022.5692
44. Miravitlles M., Ribera A. Understanding the impact of symptoms on the burden of COPD // Respir Res. 2017. 18, 67 https://doi.org/10.1186/s12931-017-0548-3
45. Mondal P., Yirinec A., Midya V. Diagnostic value of spirometry vs impulse oscillometry: a comparative study in children with sickle cell disease // Pediatr Pulmonol. 2019. 54:9.
46. Nugmanova D, Feshchenko Y, Iashyna L. The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study // BMC Pulm Med. 2018. 18: 26 (94).
47. Occhipinti M, Paoletti M, Bigazzi F, et al. Emphysematous and non emphysematous gas trapping in chronic obstructive pulmonary disease: quantitative CT findings and pulmonary function // Radiology. 2018. 287(2):683-692.
48. Pare P. Site and nature of airway obstruction in chronic obstructive lung disease: 50 years on // Canadian Journal of Respiratory, Critical care and Sleep Medicine. 2019. 3: https://doi.org/10.1080/24745332.2019.1572479
49. Postma D.S., Brightling C., Baldi S., Van den Berge M., Fabbri L.M., Gagnatelli A. et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study // Lancet Respir Med. 2019 7:402–16. doi: 10.1016/S2213-2600(19)30049-9
50. Pompe E., Galbán C.J., Ross B.D. et al. Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease // Respir Med. 2017. 123:48-55
51. Porojan-Suppini N., Fira-Mladinescu O., Marc M., Tudorache E., Oancea C. Lung Function Assessment by Impulse Oscillometry in Adults // Ther Clin Risk Manag. 2020 Nov 26.16:1139-1150. doi: 10.2147/TCRM.S275920.
52. Qin S., Yu X., Ma Q., Lin L., Li Q., Liu H., Zhang L., Leng S., Han W. Quantitative CT Analysis of Small Airway Remodeling in Patients with Chronic Obstructive Pulmonary Disease by a New Image Post-Processing System // Int J Chron Obstruct Pulmon Dis. 2021. 16:535-544. https://doi.org/10.2147/COPD.S295320
53. Rabe K.F., Watz H. Chronic obstructive pulmonary disease // Lancet. 2017. 389(10082):1931-1940.
54. Rutting S, Badal T, Wallis R. et al. Long-term variability of oscillatory impedance in stable obstructive airways disease // European Respiratory Journal. 2021. 58: 2004318. DOI:10.1183/13993003.04318-2020
55. Stockley J.A., Cooper B.G., Stockley R.A., Sapey E. Small airways disease: time for a revisit? // Int J Chron Obstruct Pulmon Dis. 2017. 12:2343-2353
56. Stockley J.A., Ismail A., Hughes S.M., Edgar R.E., Stockley R.A., Sapey E. Mid maximal expiratory flow detects early lung disease in alpha 1 antitrypsin deficiency // Eur Respir J. 2017. 49:3.
57. Sylvester K.P., et al. ARTP statement on pulmonary function testing 2020 // BMJ Open Resp Res 2020;7:e000575. doi:10.1136/bmjresp-2020-000575
58. Saeid Safiri, Kristin Carson-Chahhoud, Maryam Noori. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019 // BMJ. 2022. 378. doi:https://doi.org/10.1136.
59. Schnieders E., Ünal E., Winkler V. et al. Performance of alternative COPD case-finding tools: a systematic review and meta-analysis // Eur Respir Rev. 2021. 30(160):200350. doi: 10.1183/16000617.0350-2020
60. Suzanne G. Bollmeier, Aaron P. Hartmann, Management of chronic obstructive pulmonary disease: A review focusing on exacerbations // American Journal of Health-System Pharmacy, Volume 77, Issue 4, 15 February 2020. 259–268, https://doi.org/10.1093/ajhp/zxz306
61. Soares M., Richardson M., Thorpe J., Owers-Bradley J., Siddiqui S. Comparison of Forced and Impulse Oscillometry Measurements: A Clinical Population and Printed Airway Model Study // Sci Rep. 2019 Feb 14. 9(1):2130. doi: 10.1038/s41598-019-38513-x.
62. Tao Li, Hao-Peng Zhou, Zhi-Jun Zhou et al. Computed tomography-identified phenotypes of small airway obstructions in chronic obstructive pulmonary disease // Chin Med J. 2021 Sep 5; 134(17): 2025–2036. doi:10.1097/CM9.0000000000001724.
63. Trinkmann F., Watz H., Herth F.J.F. Why do we still cling to spirometry for assessing small airway function? // Eur Respir J. 2020. 56:2001071. doi: 10.1183/13993003. 01071-2020
64. Usmani O, Dhand R, Lavorini F, Price D. Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease // Mayo Clin Proc. 2021. 96(9):2448-2463 https://doi.org/10.1016/j.mayocp.2021.03.016
65. Vogelmeier C.F., Criner G.J., Martinez F.J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary // Am J Respir Crit Care Med. 2017. 195(5):557–582.
66. Wytse B., van den Bosch, Alan L. James, Harm A.W.M. Tiddens. Structure and function of small airways in asthma patients revisited. European Respiratory Review. 2021. 30: 200186. DOI:10.1183/16000617.0186-2020
67. Yang Y. et al. Structural features on quantitative chest computed tomography of patients with maximal mid-expiratory flow impairment in a normal lung function population // BMC Pulm Med. 2023. 23, 86. https://doi.org/10.1186/s12890-023-02380-0
68. Young Hoon Cho, Joon Beom Seo, Sang Min Lee et al. Quantitative CT Imaging in Chronic Obstructive Pulmonary Disease: Review of Current Status and Future Challenges // J Korean Soc Radiol. 2018. 78(1):1-12.
69. Zhumagaliyeva A.N, Ottaviani S, Greulich T et al. Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD. Multidisciplinary Respiratory Medicine. 2017. 12:23 DOI 10.1186/s40248-017-0104-5.
70. Zhumagaliyeva A.N.Alpha-1 antitrypsindeficiency and chronic obstructive pulmonary disease. Science & Healthcare, 2016. 1: р. 127-136.
Количество просмотров: 2303
Категория статей:
Обзор литературы
Библиографическая ссылка
Жұмағалиева А., Бакенова Р., Кемешова М., Нәзілова М., Нәзілова Ж. Кіші тыныс жолдары ауруы – ӨСОА ерте нақтамалаудың болжамы // Ғылым және Денсаулық сақтау. 2024. Т.26 (2). Б. 192-200. doi 10.34689/SH.2024.26.2.022Похожие публикации:
UNDERSTANDING OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN AT THE PRESENT STAGE. REVIEW.
ГЕМОДИНАМИЧЕСКИ ЗНАЧИМЫЙ ОТКРЫТЫЙ АРТЕРИАЛЬНЫЙ ПРОТОК У НЕДОНОШЕННЫХ НОВОРОЖДЕННЫХ ДЕТЕЙ. ОБЗОР ЛИТЕРАТУРЫ
RADIOIODINE-RESISTANT DIFFERENTIATED THYROID CANCER: CLINICOPATHOLOGICAL CHARACTERISTICS, MOLECULAR GENETIC ALTERATIONS. REVIEW.
ПРЕРЫВИСТАЯ КАТЕТЕРИЗАЦИЯ МОЧЕВОГО ПУЗЫРЯ КАК «ЗОЛОТОЙ СТАНДАРТ» ЛЕЧЕНИЯ НЕЙРОГЕННОГО МОЧЕВОГО ПУЗЫРЯ У ЛИЦ, С ПОВРЕЖДЕНИЕМ СПИННОГО МОЗГА
АНАЛИЗ ОПЫТА МЕДСЕСТЕР И ФАКТОРОВ, ВЛИЯЮЩИХ НА ДОБРОВОЛЬНОЕ СООБЩЕНИЕ ОБ ИНЦИДЕНТАХ